Clinical aspects of coenzyme Q10: An update

Nutrition

Volumn 26, Issue 3, 2010, Pages 250-254

  Littarru, Gian Paolo ^a   Tiano, Luca ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cardiovascular disease; Coenzyme Q10; Mitochondrial myopathies; Reproductive medicine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SUPEROXIDE DISMUTASE; TAMOXIFEN; UBIDECARENONE;

BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIASTOLIC DYSFUNCTION; DOSE RESPONSE; DOWN SYNDROME; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERANCE; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; EXERCISE; FATIGUE; FRIEDREICH ATAXIA; GENE MUTATION; GENITAL SYSTEM DISEASE; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; INTESTINE OBSTRUCTION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LONG TERM CARE; LOW DRUG DOSE; MALE INFERTILITY; MATERNALLY INHERITED DIABETES AND DEAFNESS; MIGRAINE; MYALGIA; MYOPATHY; OLIGOSPERMIA; OXIDATIVE STRESS; PARKINSON DISEASE; POSTPOLIOMYELITIS SYNDROME; PREECLAMPSIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REPERFUSION INJURY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT RESPONSE;

CARDIOVASCULAR DISEASES; ENERGY METABOLISM; EXERCISE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PREGNANCY; UBIQUINONE; VITAMINS;

EID: 75749150806     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.08.008     Document Type: Review

References (49)

1. 10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 37 (2005) 1208-1218
2. 10: an update. Curr Opin Clin Nutr Metab Care 8 (2005) 641-646
3. 10 and exercise training in chronic heart failure. Eur Heart J 27 (2006) 2675-2681
4. 10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28 (2007) 2249-2255
5. 10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 21 (2007) 297-306
6. 10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM). Biofactors 32 (2008) 145-149
7. 10 and coronary artery bypass surgery: what we have learned from clinical trials. J Cardiothorac Vasc Anesth 2009, Epub ahead of print.
8. 10 in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 22 (2008) 832-839
9. 10 and differences in coronary heart disease risk in Asian Indians and Chinese. Free Radic Biol Med 32 (2002) 132-138
10. 10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol 52 (2008) 1435-1441
11. 10 and statins: biochemical and clinical implications. Mitochondrion 7 suppl (2007) S168-S174
12. 10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol 49 (2007) 2231-2237
13. 10 level in statin-related myopathy. Arch Neurol 62 (2005) 1709-1712
14. Laaksonen R., Jokelainen K., Sahi T., Tikkanen M.J., and Himberg J.J. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin Pharmacol Ther 57 (1995) 62-66
15. Paiva H., Thelen K.M., Van Coster R., Smet J., De Paepe B., Mattila K.M., et al. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 78 (2005) 60-68
16. 10 and brain natriuretic peptide in patients with coronary artery disease. Int Heart J 49 (2008) 423-433
17. Young J.M., Florkowski C.M., Molyneux S.L., McEwan R.G., Frampton C.M., George P.M., and Scott R.S. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol 100 (2007) 1400-1403
18. 10 on myopathic symptoms in patients treated with statins. Am J Cardiol 99 (2007) 1409-1412
19. 10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 91 (2009) 1785-1792
20. 10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol 182 (2009) 237-248
21. 10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet 105 (2009) 43-45
22. Teran E., Escudero C., Vivero S., Molina G., and Calle A. NO in early pregnancy and development of preeclampsia. Hypertension 47 (2006) e17
23. 10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 5 (2008) 8
24. 10 during physical fatigue. Nutrition 24 (2008) 293-299
25. 10. Br J Nutr 100 (2008) 903-909
26. Hellsten Y., Nielsen J.J., Lykkesfeldt J., Bruhn M., Silveira L., Pilegaard H., and Bangsbo J. Antioxidant supplementation enhances the exercise-induced increase in mitochondrial uncoupling protein 3 and endothelial nitric oxide synthase mRNA content in human skeletal muscle. Free Radic Biol Med 43 (2007) 353-361
27. Tauler P., Ferrer M.D., Sureda A., Pujol P., Drobnic F., Tur J.A., and Pons A. Supplementation with an antioxidant cocktail containing coenzyme Q prevents plasma oxidative damage induced by soccer. Eur J Appl Physiol 104 (2008) 777-785
28. 10 on autonomic nervous activity and energy metabolism during exercise in healthy subjects. J Nutr Sci Vitaminol (Tokyo) 54 (2008) 286-290
29. 10 supplementation in patients with post-polio: a pilot study. J Rehabil Med 40 (2008) 773-775
30. 10 deficiencies. Biofactors 32 (2008) 113-118
31. Mollet J., Giurgea I., Schlemmer D., Dallner G., Chretien D., Delahodde A., et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117 (2007) 765-772
32. 10 deficiency. FASEB J 22 (2008) 1874-1885
33. 10-responsive condition. Neurology 65 (2005) 606-608
34. 10 deficiency. N Engl J Med 358 (2008) 2849-2850
35. 10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 84 (2009) 558-566
36. 10 and vitamin E therapy. Mitochondrion 7 suppl (2007) S127-S135
37. 10 therapy. Eur J Neurol 15 (2008) 1371-1379
38. Henchcliffe C., and Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4 (2008) 600-609
39. 10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59 (2002) 1541-1550
40. 10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 23 (2008) 942-949
41. 10 on UVB-induced wrinkle formation in vitro and in vivo. Biofactors 32 (2008) 237-243
42. 10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects. Biofactors 32 (2008) 161-167
43. 10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr Neurol 37 (2007) 398-403
44. 10 supplementation to breast cancer patients undergoing Tamoxifen therapy. Biofactors 32 (2008) 151-159
45. 10. Arq Bras Endocrinol Metabol 52 (2008) 1345-1349
46. 10 in migraine prophylaxis: a randomized controlled trial. Neurology 64 (2005) 713-715
47. 10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47 (2007) 73-80
48. Dallner G., Stocker R., and Coenzyme Q. In: Paul C. (Ed). Encyclopedia of dietary supplements (2005), Marcel Dekker, New York 121-131
49. Genova M.L., Bianchi C., and Lenaz G. Supercomplex organization of the mitochondrial respiratory chain and the role of the coenzyme Q pool: pathophysiological implications. BioFactors 25 (2005) 5-20